Entry | Author | Date | Location | |
---|---|---|---|---|
The Near Death, and Second Life, of Cerulean Pharma | Ben Fidler | 07/13/15 | Boston | |
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO | Ben Fidler | 11/14/14 | San Francisco | |
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race | Ben Fidler | 06/09/14 | Boston | |
Page 1 of 1 | ||||